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Abstract 
Acyl-coenzyme A:cholesterol acyltransferase (ACAT) is the intracellular enzyme responsible for the 
esterification of cholesterol with long-chain fatty acyl-CoA derivatives and has been implicated in 
atherosclerosis and gallstone disease. The effects of exogenous cholesterol and dithiothreitol (DTT) on 
the ACAT activity of human liver microsomes have been determined. Pre-incubation of microsomes 
with exogenous cholesterol gave a marked stimulation of activity. Experiments with [3H]cholesterol 
and [14C]ololeoyl-CoA indicated the time course of equilibration of exogenous with endogenous 
cholesterol as ACAT substrates, and showed that ACAT activity could be accurately measured using 
[3H]cholesterol/Tween 80, provising that the concentration of endogenous microsomal cholesterol was 
also determined. Pre-incubation of liver microsomes for 90 min in the presence of 2 mmol/1 DTT and 
exogenous cholesterol/Tween 80 resulted in a 60% reduction in ACAT activity, compared with the 
corresponding activity when DTT was omitted. If microsomes were pre-incubated with DTT prior to 
the pre-incubation with exogenous cholesterol/Tween 80, and 85–90% reduction in ACAT activity 
occurred. In contrast, pre-incubation of microsomes with DTT in the absence of exogenous 
cholesterol/Tween 80 (only endogenous cholesterol present) resulted, initially in a stimulation of 
ACAT activity; on further pre-incubation, activity returned to control levels. These results indicate that 
the supply of cholesterol to the enzyme active site is an important factor in ACAT assays in vitro and 
that DTT has a major effect on this process, suggesting that these factors may be important in 
controlling ACAT activity in vivo.  
Author Keywords: Acyl-CoA hydrolase; cholesterol availability in ACAT assay; cholesterol 
transport protein; atherosclerosis; gallstones  
 
1. Introduction 
Acyl-coenzyme A:cholesterol acyltransferase (ACAT; E.C. 2.3.1.26) is located in the rough 
endoplasmic reticulum [1-5] where it catalyses the esterification of cholesterol with long-
chain fatty acyl-CoA derivatives. ACAT activity is subject to regulation by diet, substrate 
supply, circadian rhythm and hormones [6-10] and has been shown to play an important role 
in diseases such as atherosclerosis [11-14] and cholesterol gallstones [15]. The importance of 
ACAT in cholesterol absorption from the gut [16-18], its involvement in synthesizing 
cholesterol ester in the liver for secretion into plasma in very low density lipoproteins [19,20] 
and its role in converting cholesterol into cholesterol ester in arterial tissues [12-14] have all 
made ACAT a good target for modulation by therapeutic drugs [12-14,18,21]. 
 It has been previously demonstrated that endogenous cholesterol present in rat, 
monkey and human liver microsomes can act as a substrate for ACAT and that the addition of 
exogenous cholesterol to the assay mixture stimulates activity several-fold [2,11,22-28]. In 
the present work, we used a dual label method ([3H]cholesterol and [14C]oleoyl-CoA) to 
compare the utilisation of endogenous and exogenous cholesterol by ACAT in a standard 
assay [27]. 
 Several groups have reported that inclusion of DTT in the assay decreased ACAT 
activity in vitro [3,25,27,29], suggesting the possible role of a thiol such as glutathione in the 
regulation of ACAT activity in vivo. Thiols, including glutathione, have been shown to 
activate HMG-CoA reductase [30,31] and cholesterol 7α-hydroxylase [32,33], two other 
important enzymes of cholesterol metabolism. Early work by Goodman et al. [34] indicated 
that ACAT activity may also be modulated by glutathione. It is therefore possible that the 
activities of HMG-CoA reductase, cholesterol 7α-hydroxylase and ACAT are co-ordinately 
controlled by a redox mechanism. In this paper, we describe the effects of pre-incubation of 
microsomes with DTT, in the presence and absence of exogenous cholesterol/Tween 80, on 
ACAT activity. 
 
2. Materials and methods 
2.1. Liver samples 
Human liver tissue was obtained from several organ donors who died either from head 
injuries, cerebral tumour, meningioma or from hypoxic brain death, with no other known 
medical condition. The portion of liver not required for transplantation was used. All livers 
were subject to minimal warm ischaemia (i.e. storage at 37°C in the absence of blood flow) 
and several hours of cold ischaemia by perfusion in situ with cold flush solution 
(hyperosmolar Collins C2 solution [35,36]) before storage at –70°C. Microsomal membrane 
fractions were prepared as previously described [37]. Liver samples obtained and processed 
by these procedures have been previously found to be suitable for studies on hepatic ACAT 
activity [15,27,36]. Consent for use of liver tissue for scientific purposes was obtained from 
the next of kin. 
 
2.2. Dual label experiments 
ACAT activity was determined as previously described [15,27] with the exception that 
[3H]cholesterol was included in the cholesterol/Tween 80 solution (6 µg cholesterol and 150 
µg Tween 80 per assay) and the [3H]cholesterol oleate internal standard was omitted from the 
assay. The ACAT assay buffer was Tris-HC1, pH 8.4 [27]. Specific activity was calculated by 
using both the specific activity of the [14C]oleoyl-CoA added to the assay and the specific 
activity of the [3H]cholesterol, after adjusting for the amount of endogenous cholesterol, 
assuming that equilibrium existed between the endogenous and exogenous cholesterol. 
 
2.3. Other assays 
Microsomal cholesterol concentrations were determined by the method of Salè et al. [38] and 
protein by the method of Lowry et al. [39] as modified by Peterson [40]. 
 
3. Results 
3.1. Effect of exogenous [3H]cholesterol/Tween 80 on ACAT activity 
The effect of exogenous cholesterol on ACAT activity was investigated by pre-incubating 
[3H]cholesterol dispersed in Tween 80 with human liver microsomes for various times and 
subsequently initiating ACAT activity by the addition of [14C]oleoyl-CoA (Fig. 1A). 
ACAT activity was determined by measuring the rate of incorporation of both 3H from 
[3H]cholesterol and 14C from [14C]oleoyl-CoA into cholesterol oleate. Results in Fig. 1A 
demonstrate that the activity determined by both methods was markedly increased by pre-
incubation, indicating that activity depends on substrate supply.  
 
 
Fig. 1. Effect of pre-incubation of microsomes with exogenous [3H]cholesterol/Tween 80 in the 
absence (A) and presence (B) of 2 mmol/1 DTT. ACAT specific activity was calculated using both the 
specific activity of [14C]oleoyl-CoA (z) and [3H]cholesterol (); both the endogenous (3537 pmol) 
and exogenous (15 520 pmol) cholesterol were used in the calculation. Duplicates varied by less than 
10%. 
 
Furthermore, the specific activities determined by both methods, taking into account the 
endogenous microsomal cholesterol concentration, were the same following a pre-
incubation time of greater than 30 min, indicating that the pools of endogenous and 
exogenous cholesterol had equilibrated. At shorter pre-incubation times, the specific 
ACAT activity was lower, if calculated using 3H rather than 14C incorporation, indicating 
that endogenous cholesterol was being used in preference to exogenous cholesterol. 
 With zero pre-incubation, only 10-20% of the cholesterol incorporated into 
cholesterol oleate during the 5 min reaction time was from the exogenous pool (Fig. 1; 
comparison of 14C and[3H incorporation at zero time). 
 
3.2. Effect of DTT on equilibration of exogenous and endogenous cholesterol pools on 
ACAT activity 
Previous studies from our laboratory demonstrated that the inclusion of 2 mmol/1 DTT in 
ACAT assays produced maximal inhibition of ACAT activity [27]; higher concentrations 
(5 and 10 mmol/1) had no additional effect on activity. Therefore, 2 mmol/1 DTT was 
chosen for the current experiments. When DTT (2 mmol/l) was included in the pre-incubation 
mixture together with [3H]cholesterol/Tween 80, the nett effect of pre-incubation was also to 
increase ACAT activity but to a lesser extent than when DTT was absent from the assay (Fig. 
1B compared with Fig. 1A). DTT did not prevent the equilibration of endogenous and 
exogenous cholesterol, since the 3H and 14C specific activities after 90 min pre-incubation 
were the same. The initial rise in activity presumably reflects this equilibration. The final 
specific activity (30 pmol . min -1 . mg -1 at 90 min pre-incubation) shows that the effect of the 
2 mmol/l DTT was to decrease ACAT activity by approximately 60% (Fig. 1B compared with 
Fig. 1A). 
 To examine whether DTT had a direct effect on ACAT activity, human liver 
microsomes were incubated for 20 min in the presence and absence of DTT (2 retool/l) before 
incubating with [3H] cholesterol/Tween 80 for various times prior to addition of [14C]oleoyl-
CoA (Fig. 2). Incubation of microsomes in the absence of DTT had no effect on the 
subsequent stimulation by exogenous cholesterol, as expected (compare Figs. 2 and 1A). 
However, if microsomes were incubated with DTT prior to incubation with exogenous 
cholesterol, the activity was decreased by 85-90% following 30 min incubation with 
exogenous cholesterol (Fig. 2). 
 
Fig. 2. Effect of pre-incubation of microsomes with exogenous [3H]cholesterol/Tween 80 following 
incubation of microsomes for 20 rain in the absence (solid lines) and presence (dashed lines) of 2 
retool/1 DTT. ACAT specific activity was calculated as described in Fig. l. (z) [14C]oleoyl-CoA; () 
[3H]cholesterol. Duplicate assays varied by less than 10%, except for the zero and 10 rain time points 
of dashed lines in which the variation was considerably higher owing to the low specific activities at 
these time points. 
 
Thus, pre-treatment of microsomes with DTT prior to the addition of exogenous 
cholesterol/Tween 80 resulted in a greater reduction in activity than when DTT was added 
simultaneously with exogenous cholesterol/Tween 80 (compare Figs. 2 and 1B). The final ACAT 
activities in the presence of DTT of Fig. 2 (11.3 and 6.9  pmol . min -1 . mg -1) were similar to 
those obtained when activity was determined in the absence of exogenous cholesterol and DTT 
after 90 min pre-incubation of the microsomes, i.e.12 pmol . min-1 . mg -1. 
 
3.3. Effect of DTT on ACAT activity in the absence of exogenous cholesterol 
To investigate the mechanism of DTT inhibition of ACAT activity, the effect of pre-
incubation with 2 mmol/1 DTT on the activity in the absence of exogenous cholesterol 
was determined (Fig. 3).  
 
Fig. 3. Effect of pre-incubation of microsomes (in the absence of exogenous cholesterol and Tween 80) 
in the absence () or presence (z) of 2 mmol/1 DTT. ACAT specific activity was calculated by using 
the specific activity of [14C]oleoyl-CoA. [3H]Cholesterol oleate was included as an internal standard as 
previously described [27]. Duplicate assays varied by less than 10%. 
 
Pre-incubation of microsomes alone had very little effect on ACAT activity using 
endogenous cholesterol as substrate, confirming our previous studies [27]. If DTT was 
included in the reaction mixture, ACAT activity was initially stimulated (2.6 fold upon 10 
min pre-incubation) and then gradually decreased to control (DTT omitted) levels by 60 
min pre-incubation. Thus, under these assay conditions, DTT appeared to activate ACAT 
activity at some pre-incubation times and not others, arguing against a direct inhibitory 
effect of DTT on ACAT. However, this experiment differed from the earlier experiments in 
that the detergent, Tween 80 (as well as exogenous cholesterol), was not present in the 
reaction mixture. 
 The effect of Tween 80 on DTT inhibition of ACAT activity was therefore examined. 
Microsomes were pre-incubated for 90 min in the presence of Tween 80, with or without 
DTT. Tween 80 alone increased ACAT activity by 2.2 fold compared with a control 
containing no DTT (Table 1).  
 
Table 1 
Effect of Tween 80 and DTT on ACAT Activitya 
 
Additions   ACAT specific activity (pmol . min -1 . mg -1) 
None   6.3 
Tween 80b   14.1 
Tween 80 + DTTc  3.6 
DTT + Tween 80c  2.9 
 
a Microsomes were pre-incubated in assay buffer in the absence of exogenous cholesterol but with the additions 
specified for 90 min prior to initiation of the assay by addition of [14C]oleoyl-CoA. Duplicates varied by less than 
10%. 
b The amount of Tween 80 in all experiments was 150µg/assay. 
c The first named reagent was added at zero time and the second at 5 min. All additions were at 37°C. 
 
This presumably reflects an effect of the detergent on the microsomal membrane, perhaps 
leading to greater accessibility of the active site to the substrates. In the presence of Tween 
80, pre-treatment with 2 mmol/1 DTT caused a 74-79% decrease in ACAT activity compared 
with the control. This decrease was similar to that obtained when DTT was added to the assay 
mixture before exogenous cholesterol/Tween 80 (compare results in Table 1 and Fig. 2). 
Thus, the inhibitory effect of DTT on ACAT activity in the presence of Tween 80 is the same, 
whether or not exogenous cholesterol is added. 
 
4. Discussion 
 
A reliable assay for the determination of ACAT activity is of fundamental importance, 
particularly when the activity of this enzyme has been implicated in diseases such as 
atherosclerosis and gallstones. The supply of cholesterol to the active site of ACAT is an 
important factor in assays of ACAT activity of liver microsomes and presumably also in the 
endoplasmic reticulum of intact liver. Using exogenous [3H]cholesterol and [14C]oleoyl 
CoA, it is possible to determine the fraction of product cholesterol oleate which is derived 
from exogenous cholesterol. Results in Fig. 1A show the time course for equilibration 
between exogenous and endogenous cholesterol pools under standard assay conditions (in the 
presence of the detergent Tween 80). Equilibration was complete after 30 min of pre-
incubation. This experiment has delineated conditions in which factors affecting equilibration 
of exogenous and endogenous cholesterol may be investigated. It also shows that the much 
less expensive [3H]cholesterol could be used instead of [14C]oleoyl-CoA in routine ACAT 
assays, if sufficient time is allowed for pre-equilibration prior to addition of oleoyl-CoA 
(provided the concentration of endogenous cholesterol in the enzyme sample is measured to 
allow correction of the specific radioactivity of the [3H]cholesterol added). Failure to allow 
sufficient time for pre-incubation would result in a serious underestimation of ACAT activity 
(as shown by the zero time points of Fig. 1A). 
 The remaining experiments investigated the effect of DTT treatment on ACAT 
activity. The results of Fig. 1A and Fig. 1B show that the presence of 2 mmol/l DTT during 
the pre-incubation period in the standard ACAT assay had no effect on equilibration of 
endogenous and exogenous cholesterol. However, the final rate after 90 min of pre-incubation 
with DTT was approximately 60% lower than when DTT was omitted. This inhibitory effect 
of DTT on ACAT activity may be a general one, having also been reported in rat [25,29] and 
observed in hamsters (J.L. Smith and C. Lutton, unpublished observations). The results of 
Fig. 2 show that pre-treatment of microsomes in the assay buffer with 2 mmol/1 DTT prior to 
addition of cholesterol/Tween 80 had an even greater effect, resulting in loss of 85-90% of the 
ACAT activity compared with a control in the absence of DTT. DTT may have a direct effect 
on ACAT protein or an effect on the supply of substrates to the enzyme active site. A further 
possible explanation for the apparent inhibitory effect of DTT on ACAT activity was that 
DTT activates other enzymes which use oleoyl-CoA. This could, in principle, lead to a 
significant depletion of oleoyl-CoA during the assay and an apparent decrease in ACAT 
activity. We have previously found [J.L. Smith, unpublished observations] that when DTT is 
included in the ACAT assay, the activity of acyl-CoA hydrolase (also present in the 
microsomes) is increased several-fold.  
In the experiments of Fig. 1B, the maximal amount of oleoyl-CoA converted to oleic 
acid (hydrolase activity) was 11%. Work by Fiorica [29] showed that if 2 mmol/l DTT was 
included in the assay of rat liver ACAT activity, a significant amount (about equal to the 
amount of oleic acid) of unidentified polar material was produced. This material may be the 
thioester formed from oleoyl-CoA and DTT. These results suggest that depletion of oleoyl-
CoA sufficient to account for the loss of activity had not occurred during the assay period. In 
this context, we have shown that fatty acid ethyl esters are formed when ethanol is included in 
the ACAT assay [41]. 
 The results of Fig. 3 and Table 1 show the importance of the detergent Tween 80 in 
understanding the effect of DTT. When microsomes were pre-incubated with DTT in assay 
buffer and then assayed for ACAT activity in the absence of detergent and exogenous 
cholesterol, the activity at short pre-incubation times was significantly increased ~ 2.6 fold 
after 10 min; Fig. 3). After 60 min, the activity had returned to the baseline level (i.e., the 
level in the absence of DTT). Thus, the ACAT activity of intact microsomes using 
endogenous cholesterol and added oleoyl-CoA as substrates (in the absence of Tween 80), 
was stimulated by DTT, in marked contrast to the results of Figs. 1 and 2. The ACAT activity 
of human liver microsomes using endogenous cholesterol was also stimulated (2.2-fold) by 
pre-treatment with Tween 80 for 90 min (Table 1). If 2 mmol/l DTT was added with the 
Tween 80, the ACAT activity was decreased by 74-79%, consistent with the results of Figs. 1 
and 2. Therefore, pre-incubation of human liver microsomes separately with DTT and Tween 
80 both led to stimulation of ACAT activity with endogenous cholesterol, whereas pre-
incubation with DTT/Tween 80 together led to an ~ 80% decrease in ACAT activity. 
 Our hypotheses to explain these results are as follows (see also Fig. 4): 
 
(1) Treatment of microsomes with Tween 80 alone caused an increase in activity by making 
the active site more accessible to either or both of the substrates, cholesterol and oleoyl-CoA. 
Many microsomal enzymes exhibit marked stimulation by detergents (latency) which has 
been attributed to increased accessibility of the enzyme to the substrates. Notably, acyl-CoA 
hydrolase activity (which can be measured concurrently with ACAT activity) is stimulated by 
Tween 80 in the standard ACAT assay [J.L. Smith, unpublished observations]. 
 
(2) ACAT activity of intact microsomes is stimulated by DTT (Fig. 3) because the enzyme 
itself, or an auxiliary protein, requires a sulfhydryl group (cysteine side chain) for activity 
[42]. Alternatively, DTT may stabilize microsomes, maintaining the interaction of ACAT 
with the membrane components required for activity. The transient nature of the stimulation 
could be explained by depletion of the DTT during the pre-incubation period. An effect of 
DTT on ACAT itself may be masked by other factors in the presence of exogenous 
cholesterol/Tween 80 (see Fig. 4). 
 
(3) ACAT activity is inhibited by treatment of microsomes with DTT and Tween 80 because 
Tween 80 exposes an essential component of the ACAT system to DTT. The differential 
effects of DTT in the presence and absence of Tween 80 seem difficult to explain without 
invoking a second component required for activity (i.e. in addition to ACAT). One possibility 
is a transport protein, required for the transfer of cholesterol to the active site of ACAT. 
 
Fig. 4. Diagram showing possible pools of cholesterol in ACAT assay mixture and the effects of DTT. 
 
It is plausible to suggest that a transport protein is involved in the transport of 
cholesterol to the active site of ACAT (see Fig. 4) as such a transfer protein, microsomal 
triglyceride and cholesterol ester transfer protein (MTP), has been previously described [43] 
and its structure and physiological role elucidated [44]. While MTP has highest specificity for 
cholesterol ester and triglyceride it can bind and transport significant amounts of cholesterol 
[45]. Purified MTP from bovine liver contains two subunits with molecular weights of 88 000 
and 55 000. The 55 000 subunit has been recently identified as a multifunctional protein 
disulfide isomerase (PDI) which appears necessary to maintain the active structure of MTP 
[46]. It is conceivable that MTP or a similar cholesterol transport protein may be involved in 
the transport of cholesterol to the ACAT active site and that this process is inactivated by 
DTT/Tween 80 (as suggested in Fig. 4). Several cytosolic lipid transport proteins have been 
reported to transfer cholesterol from unilamellar vesicles/liposomes to membranes [47-49]. 
In the present work we have investigated the effects of exogenous cholesterol/Tween 
80, pre-incubation time and DTT on the ACAT activity of human liver microsomes. The 
results suggest that the supply of cholesterol to the active site of ACAT may be inhibited by 
DTT in the presence of Tween 80 and we have outlined a possible mechanism by which this 
may occur. The present work also delineates a framework in which factors affecting ACAT 
activity may be further investigated. The possible in vivo importance of these findings is the 
subject of further investigation. 
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